These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 30509029)
1. Brain-originated peptides as possible biochemical markers of traumatic brain injury in cerebrospinal fluid post-mortem examination. Olczak M; Kwiatkowska M; Niderla-Bielińska J; Chutorański D; Tarka S; Wierzba-Bobrowicz T Folia Neuropathol; 2018; 56(2):97-103. PubMed ID: 30509029 [TBL] [Abstract][Full Text] [Related]
2. Tau protein (MAPT) as a possible biochemical marker of traumatic brain injury in postmortem examination. Olczak M; Niderla-Bielińska J; Kwiatkowska M; Samojłowicz D; Tarka S; Wierzba-Bobrowicz T Forensic Sci Int; 2017 Nov; 280():1-7. PubMed ID: 28942078 [TBL] [Abstract][Full Text] [Related]
3. Myelin basic protein and neurofilament H in postmortem cerebrospinal fluid as surrogate markers of fatal traumatic brain injury. Bohnert S; Wirth C; Schmitz W; Trella S; Monoranu CM; Ondruschka B; Bohnert M Int J Legal Med; 2021 Jul; 135(4):1525-1535. PubMed ID: 33895854 [TBL] [Abstract][Full Text] [Related]
4. Measurement of Cerebral Biomarkers Proving Traumatic Brain Injuries in Post-Mortem Body Fluids. Ondruschka B; Sieber M; Kirsten H; Franke H; Dreßler J J Neurotrauma; 2018 Sep; 35(17):2044-2055. PubMed ID: 29732941 [TBL] [Abstract][Full Text] [Related]
5. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury? Sieber M; Dreßler J; Franke H; Pohlers D; Ondruschka B J Forensic Leg Med; 2018 Apr; 55():65-73. PubMed ID: 29471249 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis. Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123 [TBL] [Abstract][Full Text] [Related]
8. Concentration of microtubule associated protein tau (MAPT) in urine and saliva as a potential biomarker of traumatic brain injury in relationship with blood-brain barrier disruption in postmortem examination. Olczak M; Poniatowski ŁA; Niderla-Bielińska J; Kwiatkowska M; Chutorański D; Tarka S; Wierzba-Bobrowicz T Forensic Sci Int; 2019 Aug; 301():28-36. PubMed ID: 31128406 [TBL] [Abstract][Full Text] [Related]
11. Correlation of mechanical impact responses and biomarker levels: A new model for biomarker evaluation in TBI. Li Y; Zhang L; Kallakuri S; Cohen A; Cavanaugh JM J Neurol Sci; 2015 Dec; 359(1-2):280-6. PubMed ID: 26671128 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid viral load and biomarkers of neuronal and glial cells in Ramsay Hunt syndrome. Lindström J; Grahn A; Zetterberg H; Studahl M Eur J Neurosci; 2016 Dec; 44(11):2944-2949. PubMed ID: 27643680 [TBL] [Abstract][Full Text] [Related]
13. Serum-Based Phospho-Neurofilament-Heavy Protein as Theranostic Biomarker in Three Models of Traumatic Brain Injury: An Operation Brain Trauma Therapy Study. Yang Z; Zhu T; Mondello S; Akel M; Wong AT; Kothari IM; Lin F; Shear DA; Gilsdorf JS; Leung LY; Bramlett HM; Dixon CE; Dietrich WD; Hayes RL; Povlishock JT; Tortella FC; Kochanek PM; Wang KKW J Neurotrauma; 2019 Jan; 36(2):348-359. PubMed ID: 29987972 [TBL] [Abstract][Full Text] [Related]
14. Prolonged Cerebrospinal Fluid Neurofilament Light Chain Increase in Patients with Post-Traumatic Disorders of Consciousness. Bagnato S; Grimaldi LME; Di Raimondo G; Sant'Angelo A; Boccagni C; Virgilio V; Andriolo M J Neurotrauma; 2017 Aug; 34(16):2475-2479. PubMed ID: 28385104 [TBL] [Abstract][Full Text] [Related]
15. Valproic Acid Treatment Decreases Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels in Swine Subjected to Traumatic Brain Injury. Korley FK; Nikolian VC; Williams AM; Dennahy IS; Weykamp M; Alam HB J Neurotrauma; 2018 May; 35(10):1185-1191. PubMed ID: 29415612 [TBL] [Abstract][Full Text] [Related]
16. Characterization and standardization of multiassay platforms for four commonly studied traumatic brain injury protein biomarkers: a TBI Endpoints Development Study. Sarkis GA; Zhu T; Yang Z; Li X; Shi Y; Rubenstein R; Yost RA; Manley GT; Wang KK Biomark Med; 2021 Dec; 15(18):1721-1732. PubMed ID: 34674546 [TBL] [Abstract][Full Text] [Related]
17. Post-mortem detection of neuronal and astroglial biochemical markers in serum and urine for diagnostics of traumatic brain injury. Olczak M; Poniatowski ŁA; Siwińska A; Kwiatkowska M Int J Legal Med; 2023 Sep; 137(5):1441-1452. PubMed ID: 37272985 [TBL] [Abstract][Full Text] [Related]
18. Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barré syndrome: A pilot study. Axelsson M; Sjögren M; Andersen O; Blennow K; Zetterberg H; Lycke J Acta Neurol Scand; 2018 Aug; 138(2):143-150. PubMed ID: 29624650 [TBL] [Abstract][Full Text] [Related]
19. Detection of light subunit neurofilament and glial fibrillary acidic protein in cerebrospinal fluid of Trypanosoma brucei gambiense-infected patients. Lejon V; Rosengren LE; Buscher P; Karlsson JE; Sema HN Am J Trop Med Hyg; 1999 Jan; 60(1):94-8. PubMed ID: 9988330 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseases. Constantinescu R; Mahamud U; Constantinescu C; Eriksson B; Novakova L; Olsson B; Rosengren L; Blennow K; Axelsson M Acta Neurol Scand; 2019 Sep; 140(3):177-183. PubMed ID: 31087810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]